bpc-157 randomized controlled trial 2025 for ACL recovery: hype vs. science | Adam C. Cady MHS, ATC, CSCS, PA-C posted on the topic The Hidden Risks of BPC‑157:

Oral 5-Amino-1MQ can face limitations due to variable bioavailability, degradation in the gastrointestinal tract, and first-pass metabolism in the liver

Reported side effects of lipotropic injections are generally mild and may include injection-site reactions (redness, soreness, or swelling), nausea, flushing, headache, fatigue, or lightheadedness

Delivers butyrate and supports its natural production*2,3

Specifically, BPC-157 may exert beneficial effects for healing processes in skin tissue, tendons, and bone tissues

If the diagnosis is unclear, an x-ray while holding a weight in your hand may be helpful

doi: 10.1002/acr.25142